AP-III-a4Inside our review, we have been in a position to significantly escalate the dose of CX-5461 beyond that obtained in the 1st-in-human review in sufferers with hematologic cancers. The RP2D of 475?mg/m2 on times 1, 8, and 15 of the four-week cycle, was depending on phototoxicity, which transpired In spite of strict UV gentle avoidance protoc… Read More